A Snake Toxin Derivative for Treatment of Hyponatremia and Polycystic Kidney Diseases
We are glad to announce that our paper entitled “A Snake Toxin Derivative for Treatment of Hyponatremia and Polycystic Kidney Diseases” by Stanajic-Petrovic G. et al. was recently published by a prestigious Journal. Reference: J Am Soc Nephrol.2025 Feb 1;36(2):181-192. doi: 10.1681/ASN.0000000505. Link: https://journals.lww.com/jasn/abstract/2025/02000/a_snake_toxin_derivative_for_treatment_ of.7.aspx Humana Biosciences was charged of setting up the hyponatremia model […]
VITAFOODS 2025 in Barcelona
We are excited to announce that Stefano Palea, CEO of Humana Biosciences, will attend VITAFOODS 2025 in Barcelona, Spain, May 20-22, 2025. Dr. Palea will be glad to meet you and discuss your R&D projects during this event.
Swiss Biotech Day 2025 on May 5-6
We are excited to announce that Stefano Palea, CEO of Humana Biosciences, will attend the Swiss Biotech Day 2025 on May 5-6, 2025, in Basel, Switzerland. Dr. Palea will be glad to meet you and discuss your R&D projects during this event.
A mouse preclinical model of Benign Prostatic Hyperplasia (BPH) useful to test drug candidates
Combined Sabal and Urtica Extracts (WS® 1541) Exert Anti-proliferative and Anti-inflammatory Effects in a Mouse Model of Benign Prostate Hyperplasia Prostagutt Forte (WS® 1541) was tested using an innovative experimental model of BPH in transgenic mice where Prolactin is overexpressed in luminal prostatic cells. We are pleased to announce the online publication on Frontiers in […]
Partnership with Sicoval
Created in 2002, Prologue Biotech is a business incubator, managed by the Sicoval, dedicated to biotechnology/health companies. It supports their launch and development providing a dedicated tool answering specific needs of infrastructure. The Sicoval aims to support young biotech companies providing tools to succeed, laboratories, appropriate facilities, shared resources and economic promotion. Prologue Biotech proposes animal facilities services, answering to Biotechs […]
